Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$1.03 - $1.75 $30,683 - $52,132
-29,790 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$1.43 - $1.87 $3,078 - $4,026
-2,153 Reduced 6.74%
29,790 $54,000
Q4 2018

Feb 14, 2019

BUY
$1.01 - $2.78 $26,084 - $71,796
25,826 Added 422.2%
31,943 $38,000
Q3 2018

Nov 13, 2018

BUY
$1.72 - $2.71 $10,521 - $16,577
6,117 New
6,117 $17,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.